Pages that link to "Q36175343"

The following pages link to Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation (Q36175343):

Displaying 29 items.

• Foxp3 occupancy and regulation of key target genes during T-cell stimulation (Q24623384) (← links)
• The oxazolidinone derivative locostatin induces cytokine appeasement. (Q30887007) (← links)
• CD43 signals induce Type One lineage commitment of human CD4+ T cells (Q33307067) (← links)
• Interleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver injury in mice (Q33843364) (← links)
• Tumor necrosis factor receptor subfamily 9 (Tnfrsf9) gene is expressed in distinct cell populations in mouse uterus and conceptus during implantation period of pregnancy (Q35013318) (← links)
• Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice. (Q36183600) (← links)
• Comparison of cytokine expressions in acute myocardial infarction and stable angina stages of coronary artery disease (Q36411725) (← links)
• CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice (Q36697649) (← links)
• Immunostimulatory monoclonal antibodies for cancer therapy (Q36717901) (← links)
• T-cell co-stimulatory pathways in autoimmunity (Q36972497) (← links)
• Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma (Q36975064) (← links)
• From T-cell activation signals to signaling control of anti-cancer immunity (Q36990608) (← links)
• Radiotherapy enhances antitumor effect of anti-CD137 therapy in a mouse Glioma model (Q37040400) (← links)
• Immunotherapy for liver tumors: present status and future prospects. (Q37144014) (← links)
• Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach. (Q37144901) (← links)
• IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo (Q37159129) (← links)
• Integrating costimulatory agonists to optimize immune-based cancer therapies (Q37352989) (← links)
• Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors (Q37370587) (← links)
• Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells (Q37372991) (← links)
• Regulation in chronic obstructive pulmonary disease: the role of regulatory T-cells and Th17 cells. (Q37733651) (← links)
• Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation (Q38088635) (← links)
• Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy (Q38698632) (← links)
• How Chimeric Antigen Receptor Design Affects Adoptive T Cell Therapy (Q38830813) (← links)
• Neutralizing anti-4-1BBL treatment improves cardiac function in viral myocarditis (Q40139222) (← links)
• Gene therapy using adenoviral vector encoding 4-1BBIg gene significantly prolonged murine cardiac allograft survival (Q45861249) (← links)
• Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients (Q51799957) (← links)
• S100A4 blockage alleviates agonistic anti-CD137 antibody-induced liver pathology without disruption of antitumor immunity. (Q52597566) (← links)
• Decreased 4-1BB expression on CD4+CD25 high regulatory T cells in peripheral blood of patients with multiple sclerosis (Q60187890) (← links)
• The promise of CD4+FoxP3+ regulatory T-cell manipulation in vivo: applications for allogeneic hematopoietic stem cell transplantation (Q92916933) (← links)